Cutaneous Hyalohyphomycosis Caused by Paecilomyces lilacinus Successfully Treated by Oral Voriconazole and Nystatin Packing

Mycopathologia

Volumn 172, Issue 2, 2011, Pages 141-145

  Huang, Ching Yu ^a   Sun, Pei Lun ^a,b   Tseng, Hsiang Kuang ^a,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hyalohyphomycosis; Nystatin; Paecilomyces lilacinus; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; NYSTATIN; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

AGED; CASE REPORT; DERMATOMYCOSIS; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LIVER CIRRHOSIS; MICROBIOLOGY; MYCOSIS; ORAL DRUG ADMINISTRATION; PAECILOMYCES; PATHOLOGY; REVIEW; SKIN ULCER; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; ANTIFUNGAL AGENTS; DERMATOMYCOSES; FEMALE; HUMANS; LIVER CIRRHOSIS; MYCOSES; NYSTATIN; PAECILOMYCES; PYRIMIDINES; SKIN ULCER; TREATMENT OUTCOME; TRIAZOLES;

PAECILOMYCES LILACINUS;

EID: 79960569468     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9409-7     Document Type: Review

References (16)

1. Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect. 2006; 12: 948-60.
2. Chang BP, Sun PL, Huang FY, Tsai TC, Lin CC, Lee MD, Chen YC, Sheu JC, Tsai JD. Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy. J Med Microbiol. 2008; 57: 1581-4.
3. Aguilar C, Pujol I, Sala J, Guarro J. Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother. 1998; 42: 1601-4.
4. Espinel-Ingroff A, Chaturvedi V, Fothergill A, Rinaldi MG. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol. 2002; 40: 3776-81.
5. Castelli MV, Alastruey-Izquierdo A, Cuesta I, Monzon A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother. 2008; 52: 2926-8.
6. Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 2004; 48: 2727-9.
7. Orth B, Frei R, Itin PH, Rinaldi MG, Speck B, Gratwohl A, Widmer AF. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med. 1996; 125: 799-806.
8. Schell WA. New aspects of emerging fungal pathogens. A multifaceted challenge. Clin Lab Med. 1995; 15: 365-87.
9. Hsu CH, Chuan MT, Chiu WT, Hu SL. Cutaneous hyalohyphomycosis caused by Paecilomyces marquandii-A case report. Dermatol Sin. 2006; 52-7.
10. Larone DH. Medically important fungi. 4th ed. Washington, D. C.: ASM Press; 2002.
11. Naggie S, Perfect JR. Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis. Clin Chest Med. 2009; 30: 337-53, vii-viii.
12. Itin PH, Frei R, Lautenschlager S, Buechner SA, Surber C, Gratwohl A, Widmer AF. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol. 1998; 39: 401-9.
13. Zendri E, Martignoni G, Benecchi M, Fanti F, De Panfilis G. Paecilomyces lilacinus cutaneous infection associated with a dog bite. J Am Acad Dermatol. 2006; 55: S63-4.
14. Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis. 2000; 32: 331-2.
15. Martin CA, Roberts S, Greenberg RN. Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2002; 35: e78-81.
16. van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis. 2008; 10: 117-22.